Active Biotech receives major new order for SBL Cholera Vaccine worth MSEK 11.5.Business Editors STOCKHOLM, Sweden--(BUSINESS WIRE)--Oct. 25, 2000 The authorities on the French island of Mayotte have decided that the entire population should be vaccinated against cholera. The French Ministry of Health has placed an order for immediate delivery of SBL SBL Society of Biblical Literature SBL Symbol Technologies, Inc. (NYSE symbol) SBL Spamhaus Block List SBL Space-Based Laser SBL Securities Borrowing and Lending SBL Supreme Beings of Leisure (band) Cholera Vaccine worth MSEK MSEK Meyer, Suozzi, English & Klein (New York law firm) MSEK Million Swedish Kroner 11.5. The island of Mayotte is one of the Comoran isles off the east coast of Africa, with approximately 125,000 permanent residents. The risk of a cholera epidemic breaking out on the island increases with the onset of the rainy season early in the new year. The authorities in Mayotte therefore want the inhabitants
The game is based loosely on the concepts from SameGame. to be vaccinated before then. As 98% of the population are Muslim, oral vaccines must be taken before the end of November/start of December when the month of Ramadan begins, during which fasting is observed. Cholera is an acute intestinal infection with dramatic effects, occurring primarily in Africa, Asia and South America. The disease is caused by the Vibrio cholerae Vibrio chol·er·ae n. A bacterium that causes Asiatic cholera in humans; Koch's bacillus. Vibrio cholerae Infectious disease The Vibrio bacterium, which produces a toxin that causes severe diarrhoea and usually vomiting. This can rapidly lead to death if no treatment is given. Cholera is spread via contaminated water and food. In 1999, approximately 200,000 cases of cholera were reported to the World Health Organisation (WHO), although actual figures are thought to be considerably higher. Active Biotech's drinkable cholera vaccine, SBL Cholera Vaccine, has been recommended by WHO as the only vaccine on the market with a documented effect against cholera. SBL Cholera Vaccine is produced by Active Biotech in Sweden and is being launched internationally in collaboration with the vaccine company Aventis Pasteur. Following rapid efforts by Active Biotech, a part delivery has been made in October. The remainder will be supplied within the next few weeks. Lund 24 October 2000 Active Biotech AB (publ) Sven Andreasson President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Active Biotech AB is a Swedish biotechnology company focused on the research and development of rmaceuticals and vaccines, the core competence being knowledge of the human immune system. Active tech has a high quality project portfolio and financial strength. Important products and projects include oral, SBL Cholera Vaccine, a vaccine against traveller's diarrhoea (ETEC ETEC enterotoxigenic Escherichia coli. ETEC Enterotoxic Escherichia coli, see there ), innovative drugs against MS IK) and cancer (TTS (1) See text-to-speech. (2) (Transaction Tracking System) Software that monitors a transaction until completion. In the event of a hardware or software failure, it ensures that the database is brought back to its former state before the attempt to ). The turnover of Active Biotech was SEK SEK In currencies, this is the abbreviation for the Swedish Krona. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 267 million in 1999. ------------------------------------------------------------ Denna information skickades av BIT http://www.bit.se Foljande filer finns att ladda ned: http://www.bit.se/bitonline/2000/10/25/20001025BIT00770/bit0001.doc http://www.bit.se/bitonline/2000/10/25/20001025BIT00770/bit0002.pdf |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion